Hubei Biocause Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was CNY 12,758.043 million compared to CNY 17,613.172 million a year ago. Operating income was CNY 364.940 million compared to CNY 342.013 million a year ago. Net income was CNY 224.513 million compared to CNY 384.344 million a year ago. Basic earnings per share from continuing operations was CNY 0.0454 compared to CNY 0.08 a year ago.